Kallyope, the biotech startup focused on understanding the gut-brain axis, has raised $21M in additional funding as an extension to its Series B round from investors that include Polaris Partners, Lux Capital, Two Sigma Ventures, The Column Group, Bill Gates, Illumina Ventures, and Euclidean Capital. The total Series B round is now $87M. The first close was for $66M in February of this year. Founded by Charles Zuker and Tom Maniatis in 2015, Kallyope has now raised a total of $131M over three rounds.
Nominations are now open for AlleyWatch’s 2019 NYC Tech Influencers feature.
Know someone amazing who belongs on this list? Nominate them today here. Nominations open until 12/15. Looking to drive targeted response from the NYC Tech community at scale, learn more about partnering with AlleyWatch on this initiative here.